RxDoctor Payments DataLook up a doctor →

Radhika Rao, MD

Psychiatry · Saint Louis, MONPI 1952485708

Payments from drug & device makers

$16,451in general payments, 2019–2025

Across 1,117 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$2K
  • AbbVie$2K
  • Neurocrine Biosciences, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Johnson & Johnson$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • plus $8K from 31 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Otsuka America Pharmaceutical, Inc.118$1,878
AbbVie(2 entities)135$1,603
Neurocrine Biosciences, Inc.85$1,437
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)83$1,162
Johnson & Johnson71$1,091
Takeda Pharmaceuticals U.S.A., Inc.75$1,079
Sunovion Pharmaceuticals Inc.75$1,000
Teva Pharmaceuticals USA, Inc.55$909
Lundbeck LLC52$845
Axsome Therapeutics, Inc.61$776
Alkermes, Inc.50$719
Neos Therapeutics, LP32$491
Supernus Pharmaceuticals, Inc.30$490
Vanda Pharmaceuticals Inc.23$338
Tris Pharma Inc20$327
E.r. Squibb & Sons, L.L.C.19$264
Bausch Health US, LLC16$258
Corium, LLC16$216
Eisai Inc.13$203
Jazz Pharmaceuticals Inc.13$199
Merck10$146
Ironshore Pharmaceuticals Inc.7$124
Shire North American Group Inc11$121
Idorsia Pharmaceuticals US Inc7$109
Noven Therapeutics, LLC5$86
Almatica Pharma LLC5$81
Orexo US, Inc.4$77
Indivior Inc.5$75
Arbor Pharmaceuticals, Inc.5$74
Adlon Therapeutics L.p.5$74
Avanir Pharmaceuticals, Inc.3$57
Collegium Pharmaceutical, Inc.3$52
Noven Pharmaceuticals, Inc.1$30
Hikma Pharmaceuticals USA1$21
Azurity Pharmaceuticals, Inc.1$15
Validus Pharmaceuticals LLC1$15
Aytu Biopharma, Inc.1$10

How this compares

$16,451 in reported general payments places this provider in the 90th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri →

Medicare billing

Part B allowed, 2024
$86,871
Medicare patients
287
Services billed
891

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →